Cost Optimization: Identify cost-effective materials, treatment technologies, and process routes to reduce capital and operational expenditures — whether in hydrogen production or nuclear waste conditioning — while meeting safety and quality standards.
Performance Evaluation: Assess the technical efficiency, reliability, and long-term behavior of emerging technologies, from electrolysis systems to engineered waste forms, ensuring they meet operational and regulatory performance benchmarks.
Market Feasibility: Analyze industry trends, demand forecasts, and policy incentives to determine the commercial and strategic viability of technologies in both clean energy markets and nuclear waste infrastructure development.
Risk Assessment: Identify financial, environmental, and radiological risks — such as material degradation, supply chain disruption, or public opposition — and develop mitigation strategies for each.
Investment Analysis: Deliver robust financial models to evaluate return on investment (ROI), net present value (NPV), and levelized cost metrics that support project prioritization and stakeholder buy-in.
Scalability Analysis: Evaluate the potential for scaling from lab- or pilot-scale systems to full commercial or national deployment — including challenges in process stability, supply logistics, and waste throughput.
Regulatory Compliance: Ensure all process designs, facility plans, and material flows align with current and anticipated regulatory frameworks — from environmental emissions to radioactive material handling and licensing.
Sustainability Assessment: Quantify lifecycle environmental impacts, including carbon footprint, energy use, and radiological burden, to guide alignment with global and regional sustainability goals.
Technological Benchmarking: Compare novel systems to established alternatives — such as SMRs, SAF routes, or legacy waste treatments — to highlight advantages, limitations, and innovation pathways.
Time-to-Market Estimation: Estimate the full development and deployment timeline, accounting for technical milestones, permitting requirements, and stakeholder engagement.
Integration Potential: Assess how emerging technologies interface with existing infrastructure — from grid systems to hospital radiopharmaceutical workflows — and determine where retrofits or new builds are required.